120 related articles for article (PubMed ID: 7514546)
1. Identification of an aprotinin antiviral domain.
Pellegrini A; Thomas U; Franchini M; Stöckli M; Klauser S; Hunziker P; von Fellenberg R
FEBS Lett; 1994 May; 344(2-3):261-5. PubMed ID: 7514546
[TBL] [Abstract][Full Text] [Related]
2. Identification and isolation of the bactericidal domains in the proteinase inhibitor aprotinin.
Pellegrini A; Thomas U; Bramaz N; Klauser S; Hunziker P; von Fellenberg R
Biochem Biophys Res Commun; 1996 May; 222(2):559-65. PubMed ID: 8670244
[TBL] [Abstract][Full Text] [Related]
3. CAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1.
Gordon YJ; Romanowski EG; Shanks RM; Yates KA; Hinsley H; Pereira HA
Curr Eye Res; 2009 Mar; 34(3):241-9. PubMed ID: 19274533
[TBL] [Abstract][Full Text] [Related]
4. Design of synthetic bactericidal peptides derived from the bactericidal domain P(18-39) of aprotinin.
Pellegrini A; von Fellenberg R
Biochim Biophys Acta; 1999 Aug; 1433(1-2):122-31. PubMed ID: 10446365
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids.
Ozçelik B; Kartal M; Orhan I
Pharm Biol; 2011 Apr; 49(4):396-402. PubMed ID: 21391841
[TBL] [Abstract][Full Text] [Related]
6. The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification.
Oevermann A; Engels M; Thomas U; Pellegrini A
Antiviral Res; 2003 Jun; 59(1):23-33. PubMed ID: 12834857
[TBL] [Abstract][Full Text] [Related]
7. Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection.
Siciliano R; Rega B; Marchetti M; Seganti L; Antonini G; Valenti P
Biochem Biophys Res Commun; 1999 Oct; 264(1):19-23. PubMed ID: 10527833
[TBL] [Abstract][Full Text] [Related]
8. Conformation and inhibitory properties of peptides based on the tissue kallikrein-aprotinin complex.
Deshpande MS; Boylan J; Hamilton JA; Burton J
Int J Pept Protein Res; 1991 Jun; 37(6):536-43. PubMed ID: 1717392
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of ovotransferrin derived peptides.
Giansanti F; Massucci MT; Giardi MF; Nozza F; Pulsinelli E; Nicolini C; Botti D; Antonini G
Biochem Biophys Res Commun; 2005 May; 331(1):69-73. PubMed ID: 15845359
[TBL] [Abstract][Full Text] [Related]
10. NMR structure of mussel mytilin, and antiviral-antibacterial activities of derived synthetic peptides.
Roch P; Yang Y; Toubiana M; Aumelas A
Dev Comp Immunol; 2008; 32(3):227-38. PubMed ID: 17628674
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3.
Gaikwad S; Ingle A; Gade A; Rai M; Falanga A; Incoronato N; Russo L; Galdiero S; Galdiero M
Int J Nanomedicine; 2013; 8():4303-14. PubMed ID: 24235828
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification and functional characterisation of a Kunitz-type module from chicken type VI collagen.
Bearz A; Tolazzi G; Leonardi A; Pucillo C; Tell G; Colombatti A; Formisano S
Biochem Biophys Res Commun; 1995 Oct; 215(3):1050-5. PubMed ID: 7488030
[TBL] [Abstract][Full Text] [Related]
13. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2.
Aboudy Y; Mendelson E; Shalit I; Bessalle R; Fridkin M
Int J Pept Protein Res; 1994 Jun; 43(6):573-82. PubMed ID: 7928088
[TBL] [Abstract][Full Text] [Related]
14. Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool.
Scudiero O; Nigro E; Cantisani M; Colavita I; Leone M; Mercurio FA; Galdiero M; Pessi A; Daniele A; Salvatore F; Galdiero S
Int J Nanomedicine; 2015; 10():6523-39. PubMed ID: 26508857
[TBL] [Abstract][Full Text] [Related]
15. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate.
Jenssen H; Andersen JH; Uhlin-Hansen L; Gutteberg TJ; Rekdal Ø
Antiviral Res; 2004 Feb; 61(2):101-9. PubMed ID: 14670583
[TBL] [Abstract][Full Text] [Related]
16. Effect of membranotropic and mucoadhesive formulations of protein proteinase inhibitors on bovine herpes virus-1 reproduction.
Larionova NV; Malykh EV; Villemson AL; Krasota AJ; Duchene D; Ollivon M; Gernet MV; Belousova RV; Shen WC; Larionova NI
Int J Pharm; 2003 Apr; 256(1-2):191-8. PubMed ID: 12695026
[TBL] [Abstract][Full Text] [Related]
17. Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence.
Jiang S; Lin K
Pept Res; 1995; 8(6):345-8. PubMed ID: 8838418
[TBL] [Abstract][Full Text] [Related]
18. A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.
Aytemir MD; Ozçelik B
Eur J Med Chem; 2010 Sep; 45(9):4089-95. PubMed ID: 20591538
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydrophobization of basic pancreatic proteinase inhibitor on the inhibition of bovine trypsin and human leukocyte elastase.
Malykh EV; Tyurina OP; Balabushevitch NG; Larionova NI
Biochemistry (Mosc); 1998 Oct; 63(10):1119-21. PubMed ID: 9864442
[TBL] [Abstract][Full Text] [Related]
20. Different modes of inhibition of human adenovirus proteinase, probably a cysteine proteinase, by bovine pancreatic trypsin inhibitor.
Brown MT; McGrath WJ; Toledo DL; Mangel WF
FEBS Lett; 1996 Jun; 388(2-3):233-7. PubMed ID: 8690094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
